Major health technology assessment (HTA) bodies in Canada assess the value of new health technologies like drugs, devices, and digital health tools, and make recommendations to government about what to include (and exclude) from public medicare. Their work is critically important to the overall fairness, legitimacy and sustainability of Canadian medicare. In this project we describe and analyze the extent to which Canadian HTA bodies have considered important legal issues. We are working with representatives of HTA bodies from other countries, and international HTA scholars, to create and test tools that will equip HTA bodies to identify and prioritize legal issues for deeper analysis.
